Cargando…
Targeting Tumors with Salmonella Typhimurium - Potential for Therapy
When one considers the organism Salmonella enterica serotype Typhimurium (S. Typhimurium), one usually thinks of the Gram-negative enteric pathogen that causes the severe food borne illness, gastroentertitis. In this context, the idea of Salmonella being exploited as a cancer therapeutic seems prett...
Autores principales: | Wall, Daniel M., Srikanth, C.V., McCormick, Beth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157733/ https://www.ncbi.nlm.nih.gov/pubmed/21321381 |
Ejemplares similares
-
Mucosal Inflammatory Response to Salmonella typhimurium Infection
por: Patel, Samir, et al.
Publicado: (2014) -
SipA Activation of Caspase-3 Is a Decisive Mediator of Host Cell Survival at Early Stages of Salmonella enterica Serovar Typhimurium Infection
por: McIntosh, Anne, et al.
Publicado: (2017) -
Draft Genome Sequence of the Tumor-Targeting Salmonella enterica Serovar Typhimurium Strain SL7207
por: Johnson, Síle A., et al.
Publicado: (2017) -
The oxido-reductase enzyme glutathione peroxidase 4 (GPX4) governs Salmonella Typhimurium-induced neutrophil transepithelial migration
por: Agbor, Terence A, et al.
Publicado: (2014) -
Targeted Cancer Therapy Using Engineered Salmonella typhimurium
por: Zheng, Jin Hai, et al.
Publicado: (2016)